Insight Molecular Diagnostics Inc. (IMDX) stock
IMDXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$1.78−0.08 (-4.30%)
Close on Nov 17, 2026Market cap $58.25MP/E –Yield –
Insight Molecular Diagnostics gross margin
Gross margin is gross profit as a percentage of revenue.
Insight Molecular Diagnostics's gross margin for the twelve months ending Jun 30, 2026 was 48.3%. For fiscal 2025 it was 56.7%, against 39.3% the year before. The highest annual figure on record is 64.6% in fiscal 2021.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 56.7% | +17.3 |
| FY2024 | Dec 31, 2024 | 39.3% | +11.9 |
| FY2023 | Dec 31, 2023 | 27.5% | +29.4 |
| FY2022 | Dec 31, 2022 | -1.9% | −66.5 |
| FY2021 | Dec 31, 2021 | 64.6% | +117.2 |
| FY2020 | Dec 31, 2020 | -52.5% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 65.7% | +0.4 |
| Q1 FY2026 | Mar 31, 2026 | 46.9% | −15.1 |
| Q4 FY2025 | Dec 31, 2025 | 43.5% | +3.5 |
| Q3 FY2025 | Sep 30, 2025 | 53.5% | +10.0 |
| Q2 FY2025 | Jun 30, 2025 | 65.3% | +17.2 |
| Q1 FY2025 | Mar 31, 2025 | 62.0% | +36.4 |
| Q4 FY2024 | Dec 31, 2024 | 40.0% | +77.3 |
| Q3 FY2024 | Sep 30, 2024 | 43.5% | −14.3 |
| Q2 FY2024 | Jun 30, 2024 | 48.1% | −10.7 |
| Q1 FY2024 | Mar 31, 2024 | 25.6% | +22.2 |
| Q4 FY2023 | Dec 31, 2023 | -37.3% | −27.4 |
| Q3 FY2023 | Sep 30, 2023 | 57.8% | +459.3 |
| Q2 FY2023 | Jun 30, 2023 | 58.7% | +45.7 |
| Q1 FY2023 | Mar 31, 2023 | 3.4% | −61.6 |
| Q4 FY2022 | Dec 31, 2022 | -9.9% | −82.3 |
| Q3 FY2022 | Sep 30, 2022 | -401.5% | −313.5 |
| Q2 FY2022 | Jun 30, 2022 | 13.1% | +32.5 |
| Q1 FY2022 | Mar 31, 2022 | 65.0% | +58.0 |
| Q4 FY2021 | Dec 31, 2021 | 72.5% | +114.8 |
| Q3 FY2021 | Sep 30, 2021 | -88.0% | −79.7 |
| Q2 FY2021 | Jun 30, 2021 | -19.4% | +135.8 |
| Q1 FY2021 | Mar 31, 2021 | 7.0% | +988.3 |
| Q4 FY2020 | Dec 31, 2020 | -42.3% | – |
| Q3 FY2020 | Sep 30, 2020 | -8.3% | – |
| Q2 FY2020 | Jun 30, 2020 | -155.2% | – |
| Q1 FY2020 | Mar 31, 2020 | -981.3% | – |
See a number that looks wrong?